VRI multiplex test
Rapid test for COVID-19 (SARS-CoV-2)
The Vivalytic VRI test (Viral Respiratory Tract Infections) checks the patient’s sample for the SARS CoV-2 virus, which can lead to COVID-19, as well as other possible viral respiratory diseases. To prevent the continued rapid spread of COVID-19, it is necessary to identify infectious patients with and without symptoms. With the Vivalytic VRI test, physicians can quickly and efficiently distinguish between different infections with very similar symptoms, like influenza, and immediately begin the appropriate treatment. The test delivers a reliable result based on WHO guidelines in less than 2.5 hours at the point of care, i.e. in close proximity to where the patient’s sample was collected. This means a time-consuming logistics chain, in which the samples have to be transported, is no longer necessary.
Integration of sample preparation (including process controls), DNA amplification, detection (μArray) and analysis on a single cartridge
Nucleic acid based testing for direct identification of viral pathogens
The Vivalytic Workflow
The Vivalytic analysers required for the COVID 19 rapid test can be purchased by medical institutions such as doctors’ surgeries, laboratories, hospitals and health centres. The test can be performed directly at the point of care. Are you interested in a Vivalytic Analyser for your institution? Then please contact one of our distribution partners.